vs
Side-by-side financial comparison of MACROGENICS INC (MGNX) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $41.2M, roughly 1.2× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs -14.2%). MACROGENICS INC produced more free cash flow last quarter ($42.8M vs $4.1M). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs 5.6%).
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
MGNX vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $50.3M |
| Net Profit | — | $-2.6M |
| Gross Margin | — | — |
| Operating Margin | -29.3% | -1.9% |
| Net Margin | — | -5.1% |
| Revenue YoY | 113.0% | -14.2% |
| Net Profit YoY | — | -14.5% |
| EPS (diluted) | $-0.23 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $50.3M | ||
| Q3 25 | $72.8M | $52.2M | ||
| Q2 25 | $22.2M | $60.4M | ||
| Q1 25 | $13.2M | $40.2M | ||
| Q4 24 | $19.4M | $58.6M | ||
| Q3 24 | $110.7M | $60.1M | ||
| Q2 24 | $10.8M | $46.8M | ||
| Q1 24 | $9.1M | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $16.8M | $-4.2M | ||
| Q2 25 | $-36.3M | $-2.7M | ||
| Q1 25 | $-41.0M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $56.3M | $-7.0M | ||
| Q2 24 | $-55.7M | $-12.8M | ||
| Q1 24 | $-52.2M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 98.8% | — | ||
| Q3 24 | 99.8% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 97.0% | — |
| Q4 25 | -29.3% | -1.9% | ||
| Q3 25 | 25.6% | -0.6% | ||
| Q2 25 | -165.3% | 4.8% | ||
| Q1 25 | -323.1% | -17.2% | ||
| Q4 24 | -273.0% | 2.6% | ||
| Q3 24 | 48.9% | -0.6% | ||
| Q2 24 | -538.9% | -16.4% | ||
| Q1 24 | -590.4% | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | 23.1% | -8.0% | ||
| Q2 25 | -163.0% | -4.4% | ||
| Q1 25 | -311.1% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | 50.9% | -11.7% | ||
| Q2 24 | -515.6% | -27.4% | ||
| Q1 24 | -573.3% | -29.4% |
| Q4 25 | $-0.23 | $-0.11 | ||
| Q3 25 | $0.27 | $-0.18 | ||
| Q2 25 | $-0.57 | $-0.12 | ||
| Q1 25 | $-0.65 | $-0.21 | ||
| Q4 24 | $-0.24 | $-0.11 | ||
| Q3 24 | $0.90 | $-0.31 | ||
| Q2 24 | $-0.89 | $-0.57 | ||
| Q1 24 | $-0.84 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.2M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $55.6M | $-18.2M |
| Total Assets | $256.8M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.2M | $10.5M | ||
| Q3 25 | $80.1M | $8.1M | ||
| Q2 25 | $130.7M | $9.1M | ||
| Q1 25 | $145.6M | $5.9M | ||
| Q4 24 | $182.8M | $12.4M | ||
| Q3 24 | $179.6M | $10.1M | ||
| Q2 24 | $83.9M | $9.3M | ||
| Q1 24 | $80.4M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $55.6M | $-18.2M | ||
| Q3 25 | $67.0M | $-12.1M | ||
| Q2 25 | $46.6M | $-7.7M | ||
| Q1 25 | $79.1M | $-8.1M | ||
| Q4 24 | $116.1M | $-4.4M | ||
| Q3 24 | $120.1M | $1.6M | ||
| Q2 24 | $57.8M | $6.5M | ||
| Q1 24 | $106.2M | $18.0M |
| Q4 25 | $256.8M | $434.9M | ||
| Q3 25 | $270.8M | $435.2M | ||
| Q2 25 | $245.4M | $438.1M | ||
| Q1 25 | $224.6M | $441.0M | ||
| Q4 24 | $261.7M | $471.0M | ||
| Q3 24 | $264.5M | $495.7M | ||
| Q2 24 | $201.1M | $494.9M | ||
| Q1 24 | $248.3M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.0M | $4.3M |
| Free Cash FlowOCF − Capex | $42.8M | $4.1M |
| FCF MarginFCF / Revenue | 103.8% | 8.2% |
| Capex IntensityCapex / Revenue | 0.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-83.0M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.0M | $4.3M | ||
| Q3 25 | $-30.2M | $295.0K | ||
| Q2 25 | $-47.0M | $1.6M | ||
| Q1 25 | $-46.9M | $-7.7M | ||
| Q4 24 | $-38.4M | $8.0M | ||
| Q3 24 | $60.2M | $1.3M | ||
| Q2 24 | $-44.5M | $-10.4M | ||
| Q1 24 | $-45.6M | $-2.8M |
| Q4 25 | $42.8M | $4.1M | ||
| Q3 25 | $-30.6M | $-246.0K | ||
| Q2 25 | $-47.7M | $1.2M | ||
| Q1 25 | $-47.4M | $-8.0M | ||
| Q4 24 | $-39.0M | $7.0M | ||
| Q3 24 | $59.6M | $-1.1M | ||
| Q2 24 | $-45.5M | $-10.6M | ||
| Q1 24 | $-47.1M | $-4.7M |
| Q4 25 | 103.8% | 8.2% | ||
| Q3 25 | -42.0% | -0.5% | ||
| Q2 25 | -214.5% | 1.9% | ||
| Q1 25 | -359.5% | -19.8% | ||
| Q4 24 | -201.7% | 12.0% | ||
| Q3 24 | 53.8% | -1.8% | ||
| Q2 24 | -421.6% | -22.7% | ||
| Q1 24 | -517.4% | -10.4% |
| Q4 25 | 0.6% | 0.3% | ||
| Q3 25 | 0.6% | 1.0% | ||
| Q2 25 | 3.2% | 0.6% | ||
| Q1 25 | 4.0% | 0.6% | ||
| Q4 24 | 3.2% | 1.7% | ||
| Q3 24 | 0.5% | 4.0% | ||
| Q2 24 | 9.6% | 0.5% | ||
| Q1 24 | 16.0% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | -1.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.07× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
